Tocilizumab (RoActemra/Actemra)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tocilizumab (RoActemra/Actemra), covering 2016-10-31 to 2017-06-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study on Safety and Efficacy of Tocilizumab (RoActemra/Actemra) Alone or in Combination With Non-Biologic Antirheumatics in Participants With Rheumatoid Arthritis [Phase 3]